4133 Stock Overview
Manufactures and sells various recombinant proteins and antibodies. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Abnova (Taiwan) Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$28.95 |
| 52 Week High | NT$38.85 |
| 52 Week Low | NT$28.10 |
| Beta | 0.37 |
| 11 Month Change | -3.02% |
| 3 Month Change | -5.85% |
| 1 Year Change | -10.92% |
| 33 Year Change | -21.65% |
| 5 Year Change | 7.62% |
| Change since IPO | -45.09% |
Recent News & Updates
Shareholder Returns
| 4133 | TW Life Sciences | TW Market | |
|---|---|---|---|
| 7D | -1.7% | -3.6% | -4.2% |
| 1Y | -10.9% | -13.0% | 28.9% |
Return vs Industry: 4133 exceeded the TW Life Sciences industry which returned -13% over the past year.
Return vs Market: 4133 underperformed the TW Market which returned 28.9% over the past year.
Price Volatility
| 4133 volatility | |
|---|---|
| 4133 Average Weekly Movement | 1.6% |
| Life Sciences Industry Average Movement | 4.0% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TW Market | 8.0% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 4133 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4133's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | n/a | n/a | www.abnova.com |
Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. The company’s products portfolio includes SARS-CoV/CoV-2 DNA, RNA, proteins/peptides, lysates/slides, Ab pairs/kits, Ab arrays, polyclinic antibody, beads/dyes, in situ hybridization products, systems, and automations. It also offers MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and circulating rare cell antibodies.
Abnova (Taiwan) Corporation Fundamentals Summary
| 4133 fundamental statistics | |
|---|---|
| Market cap | NT$1.75b |
| Earnings (TTM) | NT$58.90m |
| Revenue (TTM) | NT$361.19m |
29.8x
P/E Ratio4.9x
P/S RatioIs 4133 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4133 income statement (TTM) | |
|---|---|
| Revenue | NT$361.19m |
| Cost of Revenue | NT$191.14m |
| Gross Profit | NT$170.05m |
| Other Expenses | NT$111.14m |
| Earnings | NT$58.90m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.97 |
| Gross Margin | 47.08% |
| Net Profit Margin | 16.31% |
| Debt/Equity Ratio | 0.03% |
How did 4133 perform over the long term?
See historical performance and comparison